## EXPE: Expedia Group, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($247.61)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Expedia Group, Inc. $EXPE Stock Position Decreased by Fisher Asset Management LLC**
- Source: MarketBeat | 20251206T090754 | Neutral | Relevance: 99%
-  Fisher Asset Management LLC reduced its stake in Expedia Group, Inc. (NASDAQ:EXPE) by 35.7% in Q2, selling 6,503 shares and maintaining 11,691 shares valued at approximately $1.97 million. Despite this, other institutions like Norges Bank, Nuveen, and AQR significantly increased their holdings, bringing overall institutional ownership to 90.76%. Expedia recently surpassed quarterly earnings estimates and received upward price target revisions from analysts, though the consensus remains a "Hold" with an average target of $265.31.

**2. Expedia Group, Inc. $EXPE Shares Sold by Lido Advisors LLC**
- Source: MarketBeat | 20251206T111950 | Somewhat-Bullish | Relevance: 99%
-  Lido Advisors LLC significantly decreased its stake in Expedia Group, Inc. (NASDAQ:EXPE) by 88.7% in Q2, selling 38,757 shares and retaining 4,921 shares valued at approximately $830,000. Expedia recently exceeded quarterly earnings estimates with $7.57 EPS and $4.41 billion in revenue, leading to a consensus analyst price target of about $265. The company also declared a quarterly dividend of $0.40 per share, while insiders have sold a total of 4,849 shares worth approximately $1.28 million over the last 90 days.

**3. Brown Advisory Inc. Reduces Stake in Expedia Group, Inc. $EXPE**
- Source: MarketBeat | 20251209T093139 | Somewhat-Bullish | Relevance: 98%
-  Brown Advisory Inc. significantly reduced its stake in Expedia Group, Inc. by 23.8% in Q2, divesting 9,522 shares, though its remaining 30,545 shares are still valued at over $5 million. This reduction comes amidst insider selling by Director Madhumita Moina Banerjee and CAO Lance A. Soliday, yet other institutional investors have mostly increased their positions. Despite these changes, Expedia continues to perform well, beating quarterly earnings expectations and declaring a $0.40 quarterly dividend.

**4. Ardmore Road Asset Management LP Sells 165,000 Shares of Expedia Group, Inc. $EXPE**
- Source: MarketBeat | 20251207T083032 | Somewhat-Bullish | Relevance: 98%
-  Ardmore Road Asset Management LP significantly reduced its stake in Expedia Group, Inc. by selling 165,000 shares, decreasing its position by 86.8% in the second quarter. Following the sale, the firm now owns 25,000 shares valued at $4.217 million. This comes amidst other institutional investors either buying new positions or boosting their existing stakes in the online travel company.

**5. Natixis Increases Holdings in Expedia Group, Inc. $EXPE**
- Source: MarketBeat | 20251208T122111 | Bullish | Relevance: 98%
- Natixis significantly increased its stake in Expedia Group, Inc. by 1,175.3% in Q2, boosting its holdings to 166,372 shares valued at approximately $28.06 million. The online travel company also reported strong quarterly results, beating EPS and revenue estimates, and declared a $0.40 quarterly dividend. Despite various analyst target price increases, the stock maintains a consensus "Hold" rating with an average target of $265.31.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Mizuho | $270 | $240 | +12% |
| 2025-11-11 | Citigroup | $281 | $206 | +36% |
| 2025-11-10 | Argus Research | $300 | $265 | +13% |
| 2025-11-10 | Susquehanna | $265 | $200 | +32% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Mizuho | main | Neutral |
| 2025-11-11 | Citigroup | main | Neutral |
| 2025-11-10 | Argus Research | main | Buy |
| 2025-11-10 | Susquehanna | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 10 ($1.50M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-0.7%)
- Blackrock Inc.: 8.4% (-2.5%)
- JPMORGAN CHASE & CO: 8.2% (+168.5%)
- State Street Corpora: 4.8% (-2.4%)
- Windacre Partnership: 3.1% (+9.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 4 raises (avg +24%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.74 indicates undervaluation relative to growth. Forward P/E 14.8x attractive for 18% earnings growth. Quality metrics strong (ROE 54%). Analyst sentiment positive (4 raises, avg +24%). Insider selling cluster ($1.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.7B |
| Beta | 1.44 |
| 52W Range | $130.01 - $279.61 |
| Short Interest | 6.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.74 |
| Forward P/E | 14.8 |
| Current P/E | 17.5 |
| YoY Growth | 17.6% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 2.8% to 1.1% (-1.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.06% (CS: 66) | Neutral |
| RSI_14 | 62.0 | Neutral |
| MACD Histogram | 0.11 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.128x | Above |
| vs SMA200 | 1.362x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $264.41
- **Stop Loss:** $247.61 (6.4% risk)
- **Target:** $281.21 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 29
- **Position Value:** $7,667.89
- **Portfolio %:** 7.67%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-05 (Est: $3.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.95 | $7.57 | +9.0% |
| 2025Q2 | $4.13 | $4.24 | +2.6% |
| 2025Q1 | $0.36 | $0.40 | +11.5% |
| 2024Q4 | $2.10 | $2.39 | +14.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*